Tobira Therapeutics Inc. Announces Presentation of TBR-652 Data at European AIDS Conference 11/12/2009
More...
|
Concert Pharmaceuticals, Inc. Starts HIV Trial, Bags $12M From GlaxoSmithKline (GSK) to Help Challenge Gilead Sciences, Inc. (GILD)'s (JOBS) Once-Daily Pill 11/9/2009
More...
|
New GlaxoSmithKline (GSK), Pfizer Inc. (PFE) (JOBS) Company ViiV Healthcare Launches; New Specialist HIV Company Dedicated to Delivering Advances in HIV Treatment and Care 11/4/2009
More...
|
SAIC-Frederick, Inc. (SAI), Sporian Microsystems Collaborate On Device For HIV Screening in Remote Areas 11/4/2009
More...
|
Combination Antiretroviral Therapy Effective At Reducing HIV Resistance In Mothers And Babies Following Mother-to-child Transmission, Study Funded by Boehringer Ingelheim Corporation 10/28/2009
More...
|
Results Of US Army AIDS Vaccine Trial 'Weak' In Second Analysis 10/20/2009
More...
|
IL-2 No Benefit in HIV Treatment, University of Minnesota Study 10/15/2009
More...
|
Success of US Army AIDS Vaccine Trial Is at Issue 10/12/2009
More...
|
US FDA Panel Backs Wider Use of Pfizer Inc. (PFE) (JOBS) HIV Drug 10/9/2009
More...
|
Pfizer Inc. (PFE) (JOBS) HIV Drug Seems Safe for New Use Says FDA Staff 10/6/2009
More...
|
Sanofi Pasteur (SASY.PA) And VaxGen, Inc. (VXGN) AIDS Vaccine Works, But Back To The Drawing Board 9/29/2009
More...
|
University of Miami Researcher's HIV Vaccine Latest Lift In Fight Vs. AIDS 9/25/2009
More...
|
Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs Inc. (GOVX.OB) Strategy 9/24/2009
More...
|
Sanofi-Aventis (France) (SASY.PA), VaxGen, Inc. (VXGN) HIV Vaccine Shows Promise for First Time, Study Shows 9/24/2009
More...
|
U.S. FDA (JOBS) Approves Abbott Laboratories (ABT) HIV Screening Test 9/21/2009
More...
|
GeoVax Labs Inc. (GOVX.OB): Requests pre-IND Meeting With FDA Protocol Submitted for Phase 1 Therapeutic HIV/AIDS Vaccine Trial 9/21/2009
More...
|
Merck & Co., Inc. (MRK) (JOBS) Says EU Approves Isentress for New HIV Patients 9/15/2009
More...
|
Myriad Pharmaceuticals, Inc.'s Tablet Formulation of MPC-4326 Reduces Viral Load in HIV-1 Patients 9/14/2009
More...
|
Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV 9/14/2009
More...
|
Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV
9/14/2009
More...
|
Daktari Diagnostics Closes $2.8 Million Series A Round to Combat Global HIV Crisis 9/4/2009
More...
|
Study Finds Potential Way To Make An AIDS Vaccine, The Scripps Research Institute Study 9/4/2009
More...
|
Johnson & Johnson (JNJ) Strengthens Warning on HIV Drug 8/27/2009
More...
|
Mylan Inc. (MYL)'s Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment 8/18/2009
More...
|
Scientists Decode HIV Genome, University of North Carolina Study 8/6/2009
More...
|
Raltegravir Combination Treatment For HIV Is A Safe And Effective Alternative To Efavirenz In Treatment-Naive Patients, Emory University School of Medicine Study 8/4/2009
More...
|
Starpharma Holdings Ltd's VivaGel(R) Demonstrates Anti-HIV and Herpes Activity Following Human Administration 8/4/2009
More...
|
AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows, National Cancer Institute Study 8/3/2009
More...
|
University of Rouen, France Scientists Find New Strain Of HIV 8/3/2009
More...
|
Micronics Receives National Institutes of Health (NIH) SBIR Phase 2 Grant to Advance Rapid Molecular Test for HIV Diagnosis 8/3/2009
More...
|
Brain Cells Have Natural Resistance To HIV, University College Dublin Study 7/29/2009
More...
|
HIV's 'Missing Link' Detected In Ailing Chimps, University of Alabama at Birmingham Study 7/23/2009
More...
|
Abbott Laboratories (ABT) (JOBS) HIV Test Demonstrates Earlier Disease Detection 7/22/2009
More...
|
Tobira Therapeutics Inc. Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK-652 for the Treatment of HIV 7/22/2009
More...
|
Gilead Sciences, Inc. (GILD) Release: Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely in Resource-Limited Settings Without Routine Laboratory Monitoring 7/21/2009
More...
|
ISENTRESS (raltegravir), from Merck & Co., Inc. (MRK) (JOBS), was as Effective as Efavirenz at Suppressing HIV Viral Load and Increasing CD4 Cell Counts in Treatment-Naïve Patients up to 144 Weeks When Used in Combination Therapy 7/20/2009
More...
|
Tibotec Pharmaceuticals Ltd Release: 96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy 7/20/2009
More...
|
Tibotec Pharmaceuticals Ltd and Centocor Ortho Biotech Inc. Release: New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies 7/20/2009
More...
|
Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed 7/20/2009
More...
|
Circumcision Helps Protect Men, Not Women From AIDS, Johns Hopkins University Study 7/17/2009
More...
|
Gilead Sciences, Inc. (GILD) Announces Agreement With Tibotec Pharmaceuticals Ltd to Develop and Commercialize New Fixed-Dose Combination of Truvada and TMC278 7/17/2009
More...
|
Focusing HIV Treatment Helps Control Concurrent Hepatitis B Infection, Wake Forest University School of Medicine Study 7/15/2009
More...
|
Schering-Plough Corporation (SGP) Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV CCR5 Antagonist Evaluated in Novel Nucleoside-Sparing Regimen Designed to Provide Additional Treatment Options, Preserve other HIV Drugs for Subsequent Use 7/15/2009
More...
|
Brazil Proves Developing Countries Can Use Generic Medicines To Fight HIV/AIDS Epidemic, Brown University Study 7/14/2009
More...
|
New Lab Test Offers Better Prediction of HIV Microbicide Safety, Albert Einstein College of Medicine Study 7/10/2009
More...
|
FDA OKs Widened Use of Merck & Co., Inc. (MRK)'s (JOBS) Isentress HIV Drug 7/10/2009
More...
|
TB Vaccine Could Kill Babies With HIV, World Health Organization Reports 7/1/2009
More...
|
Researchers Uncover Approach For Possibly Eradicating HIV Infection, VGTI Florida And University Of Montreal Study 6/22/2009
More...
|
New Vaginal Ring Designed To Prevent Sexual Transmission Of HIV, Weill Cornell Medical College Study 5/20/2009
More...
|
Green Tea Ingredient Blocks HIV Infection, Heinrich-Pette Institute for Experimental Virology and Immunology Study 5/19/2009
More...
|
Engineered Antibodies Fight AIDS Virus In Monkeys, Children's Hospital of Philadelphia Study 5/18/2009
More...
|
Herpes Medication Does Not Reduce Risk Of HIV Transmission, University of Washington Study 5/8/2009
More...
|
India's Cipla Ltd. Gets Tentative U.S. Nod for AIDS Drug 5/5/2009
More...
|
Tests for New H.I.V. Infection Not Widely Adopted, Experts Say 5/4/2009
More...
|
Normal Vaccine Response Possible In Kids With HIV, University of Tor Vergata Study 4/30/2009
More...
|
Re-Awakening Old Genes To Help In The Fight Against HIV, University of Central Florida Study 4/28/2009
More...
|
GlaxoSmithKline (GSK) and Pfizer Inc. (PFE) Innovative Agreement Creates Specialist HIV Company 4/16/2009
More...
|
HIV Antiretroviral Treatment Should Start Earlier, University of Bristol Study 4/9/2009
More...
|
Tobira Therapeutics Inc. Initiates Proof of Concept Study with TAK-652 for the Treatment of HIV 4/9/2009
More...
|
Gum Disease May Reactivate AIDS Virus, Nihon University Study 4/3/2009
More...
|
Earlier Antiretroviral Treatment Could Reduce Risk Of Death In HIV-Positive People, Bloomberg School of Public Health Study Finds 4/3/2009
More...
|
Common Substance Used by Humans Daily "Can Kill HIV" -- AIDS Prevention Based on Cyclodextrin, Children's Hospital in Oakland Research 4/2/2009
More...
|
Potential New HIV Drug May Help Patients Not Responding To Treatment, Imperial College London Study 3/31/2009
More...
|
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Wins FDA's First Tentative Approval For Generic HIV Drug 3/31/2009
More...
|
New Vaginal Gel Stops AIDS Virus in University of Minnesota Study 3/5/2009
More...
|
GeoVax Labs Inc. (GOVX.OB) Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA Trials in South America to Follow 2/20/2009
More...
|
Gene Therapy For HIV Shows Promise, University of California, Los Angeles (UCLA) Study 2/17/2009
More...
|
HIV Progression Not Affected by Hormonal Contraception, University of Alabama at Birmingham Study 2/13/2009
More...
|
HIV Antiretroviral Medications Linked To Heart Attacks, University College Dublin Study 2/13/2009
More...
|
Preventive HIV Therapy May Limit Options for Women, Harvard School of Public Health Study 2/11/2009
More...
|
Tibotec Therapeutics's PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 2/11/2009
More...
|
Starpharma Holdings Ltd Topical Microbicide Field Receives a Boost with Human Efficacy Result 2/10/2009
More...
|
Indevus Pharmaceuticals, Inc. (IDEV) Announces AIDS Gel, PRO 2000 Found to Show Promise in Large HIV Prevention Study 2/9/2009
More...
|
Benitec Limited (BLT.AX), City of Hope Human HIV Trial Update 2/9/2009
More...
|
GlaxoSmithKline (GSK) Pays Up to $450 Million for {2} (JOBS) AIDS Drug 2/6/2009
More...
|
Sangamo BioSciences, Inc. (SGMO) Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 2/3/2009
More...
|
Myriad Pharmaceuticals, Inc. Acquires Novel HIV Drug, Bevirimat for $7 Million 1/21/2009
More...
|
Aethlon Medical (AEMD) Nears Completion of First Medical Device Study to Treat HIV/AIDS 1/15/2009
More...
|
ImQuest Pharmaceuticals, Inc. Presentations at International HIV Meeting Highlight Significant Progress in Their Therapeutic and Microbicide Development Programs 12/23/2008
More...
|
Circumcision Reduces the Risk of HIV Infection in Heterosexual U.S. Men, Centers for Disease Control and Prevention (CDC) And Johns Hopkins University Study 12/18/2008
More...
|
Synthetic Molecules Prevent HIV Virus From Reproducing Within The Body, University of Missouri Study Suggests 12/17/2008
More...
|
HIV Can Penetrate a Woman's Healthy Genital Skin, Northwestern University Study 12/17/2008
More...
|
Human DNA May Set Off AIDS Timebomb, National Cancer Institute Study 12/16/2008
More...
|
New Roche (RHHBY) Dual Target HIV-1 Test Approved for Use in European Union 12/15/2008
More...
|
Possible AIDS Treatment Shows Promise in Monkeys, Yerkes National Primate Research Center, Dana-Farber Cancer Institute, Harvard Medical School And University of Pennsylvania Study 12/11/2008
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) In-Licenses Crofelemer from Napo Pharmaceuticals, Inc. 12/10/2008
More...
|
Special Immune Cells May Be Key to HIV Resistance, National Institute of Allergy And Infectious Diseases (NIAID) Study 12/8/2008
More...
|
Profectus BioSciences, Inc. Awarded $21.6 Million in National Institutes of Health (NIH) Contracts to Develop a HIV Preventative and a HIV Therapeutic Vaccine 12/8/2008
More...
|
China AIDS Vaccine Passes Phase I Test 12/3/2008
More...
|
GeoVax Labs Inc. (GOVX.OB)'s Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 12/1/2008
More...
|
Pfizer Inc. (PFE)'s Novel HIV/AIDS Treatment SELZENTRY(TM) Becomes the Latest Fully Approved Antiretrovial for Treatment-Experienced HIV Patients 11/26/2008
More...
|
Avexa Limited (AVX.AX) Completes Recruitment for First Component of ATC Phase III Trial 11/24/2008
More...
|
HIV Tests Not Yet As Routine As Cholesterol Checks, Johns Hopkins University Expert Says 11/21/2008
More...
|
Early Treatment Best For AIDS-Infected Babies, University of Witwatersrand Study 11/20/2008
More...
|
Epidemic Of Cancers Feared With HIV Link, Johns Hopkins University Study 11/19/2008
More...
|
Tibotec Therapeutics Long-Term TITAN Study Evaluates PREZISTA(R)/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults 11/18/2008
More...
|
'Elixir Of Youth' Drug Could Fight HIV And Ageing, University of California, Los Angeles (UCLA) Study 11/14/2008
More...
|
Bone Marrow Transplant Suppresses AIDS In Patient, Berlin Charite Hospital Researchers Report 11/13/2008
More...
|
Way to Rescue Tired Immune Cells Fighting HIV Found, University of Toronto 11/13/2008
More...
|
Theratechnologies Inc. (TH.TO): Last Patient Treated in the Extension Phase of the Confirmatory Study Testing Tesamorelin in HIV-Associated Lipodystrophy 11/13/2008
More...
|
Souped-Up Immune Cells Catch Even Disguised HIV, Researchers From Adaptimmune Limited, University of Cardiff, And University of Pennsylvania Say 11/10/2008
More...
|
New York City Mayor Bloomberg and Other Honorees Celebrate Opening of the First Laboratory Solely Devoted to the Development of an AIDS Vaccine 11/10/2008
More...
|
Herpes Drug Inhibits HIV Replication, But With A Price, Johns Hopkins University Study 11/7/2008
More...
|
How Merck & Co., Inc. (MRK) HIV Vaccine Might Have Increased Odds Of Infection, Montpellier Institute of Molecular Genetics Study 11/6/2008
More...
|
OraSure Technologies, Inc. (OSUR) to Sell OraQuick ADVANCE Rapid HIV-1/2 Antibody Test Directly to U.S. Hospitals 11/6/2008
More...
|
International AIDS Vaccine Initiative Release: New York City Celebrates Opening of the First Laboratory Solely Devoted to the Development of an AIDS Vaccine 11/5/2008
More...
|
Centre Hospitalier Universitaire Vaudois, Swiss Vaccine Research Institute and Institut Génétique Moléculaire Montpellier: Study Sheds Light on the Mechanisms of Increased Risk of HIV Infection in the Step HIV Vaccine Trial 11/3/2008
More...
|
Panacos Pharmaceuticals Inc. (PANC) Announces Preliminary Results of Bevirimat Study 204 10/28/2008
More...
|
New Merck & Co., Inc. (MRK) Phase 3 HIV Drug Works in Untreated Patients 10/27/2008
More...
|
Progenics Pharmaceuticals, Inc. (PGNX) Reports Positive Interim Phase 2 Results for Two Dosage Forms of Novel HIV Therapy PRO 140 10/27/2008
More...
|
AIDS Treatment Should Start Sooner, University of Washington Led Study Finds 10/27/2008
More...
|
Schering-Plough Corporation (SGP) Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 10/27/2008
More...
|
Pfizer Inc. (PFE)’s Novel HIV/AIDS Treatment Selzentry(TM) (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naïve HIV Patients 10/27/2008
More...
|
Progenics Pharmaceuticals, Inc. (PGNX) Reports Positive Interim Phase 2 Results for Two Dosage Forms of Novel HIV Therapy PRO 140 10/27/2008
More...
|
Ardea Biosciences, Inc. Presents Additional Phase 2a and Preclinical Data on its Lead HIV Product Candidate, RDEA806, at the 48th Annual ICAAC/IDSA 46th Annual Meeting 10/27/2008
More...
|
Bristol-Myers Squibb Company (BMY) Release: 96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ® (atazanavir sulfate)/Ritonavir and Twice-Daily Lopinavir/Ritonavir In Previously Untreated HIV-1 Infected Adult Patients 10/27/2008
More...
|
Inflammation, Coagulation Tied to Non-AIDS Deaths in HIV Cases, International Network for Strategic Initiatives in Global HIV Trials Study 10/22/2008
More...
|
FDA Approves Tibotec Therapeutics' PREZISTA(R) Once-Daily as Part of Combination Therapy for Treatment-Naive Adults with HIV-1 10/22/2008
More...
|
National Cancer Institute Researchers Identify Novel Type Of Antibody That Potently Inhibits HIV Infection 10/21/2008
More...
|
HIV Can Re-Emerge From a Single Cell, Zurich University Hospital Discovers 10/21/2008
More...
|
"E-Cards" May Aid In STD Notification 10/21/2008
More...
|
Ardea Biosciences, Inc. Awarded Composition of Matter Patent Covering RDEA806, Its Lead NNRTI for the Treatment of HIV 10/20/2008
More...
|
Preliminary Phase I Safety Data for Preventive HIV Vaccine Delivered by Ichor Medical Systems, Inc.’s TriGrid to be Presented at AIDS Conference 10/17/2008
More...
|
Efavirenz-Based Initial Therapies Associated with Better Outcomes in HIV-Infected Adults, Johns Hopkins University, Bloomberg School of Public Health Study 10/15/2008
More...
|
Scientists Bleak About AIDS Vaccine Prospects, National Institute of Allergy And Infectious Diseases (NIAID) Warns 10/15/2008
More...
|
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Presents Non-Human Primate Study Data at AIDS Vaccine 2008 Conference 10/15/2008
More...
|
Body's Anti-HIV Drug Explained By University of Southern California Researchers 10/13/2008
More...
|
Calypte Biomedical Corporation (CYPT) Receives Large Order for Aware Diagnostic Test from Middle Eastern Distributor Lifeline Scientific 10/13/2008
More...
|
OraSure Technologies, Inc. (OSUR) Helps Expand Access to Rapid HIV Testing in Recognition of National Latino AIDS Awareness Day, October 15, 2008 10/13/2008
More...
|
Circumcision Doesn't Reduce HIV Risk In Gay Men, Centers For Disease Control And Prevention Study Says 10/8/2008
More...
|
Panacos Pharmaceuticals Inc. (PANC)’ Study 114 Supports The Company’s New Tablet Formulation Of Bevirimat 10/8/2008
More...
|
Pfizer Inc. (PFE) Drug Maraviroc Helps Advanced HIV At 48-Week Mark 10/2/2008
More...
|
GenVec Inc. (GNVC) Receives Third-Year Funding from National Institute of Allergy And Infectious Diseases (NIAID) for HIV Vaccine Contract Valued Up to $52 Million 10/2/2008
More...
|
Chembio Diagnostics, Inc. (CEMI.OB) And Oswaldo Cruz Foundation Sign Agreement For DPP(R) Oral Fluid - Whole Blood HIV Test 10/2/2008
More...
|
New $30M California Institute To Focus On AIDS Vaccine; The Scripps Research Institute and International AIDS Vaccine Initiative Joint Venture 10/1/2008
More...
|
University of Missouri Scientists ‘See’ How HIV Matures Into An Infection 10/1/2008
More...
|
University of Michigan Scientists Unmask Key HIV Protein, Open Door For More Powerful AIDS Drugs 9/29/2008
More...
|
Existing Anti-obesity Drugs May Be Effective Against Flu, Hepatitis And HIV, University of Rochester Medical Center and Princeton University Study 9/29/2008
More...
|
Aethlon Medical (AEMD) Initiates First Clinical Study Of a Medical Device to Treat HIV/AIDS Patients 9/29/2008
More...
|
Ranbaxy Laboratories AIDS Drugs Won't Be Funded by U.S. Program 9/26/2008
More...
|
Successful Results for MYMETICS Corporation's Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceed Expectations 9/25/2008
More...
|
Merck & Co., Inc. (MRK) Release: Isentress™ (Raltegravir) Awarded Prix Galien USA Top Honor 9/25/2008
More...
|
Researchers at The Wistar Institute Invigorate 'Exhausted' Immune Cells 9/19/2008
More...
|
Brazil To Make Generic Version Of Key AIDS Drug 9/18/2008
More...
|
Myriad Genetics, Inc. (MYGN)'s HIV Drug Shows Favorable Safety Profile 9/17/2008
More...
|
Herpes Virus Changes Anti-Herpes Drug to Form that Hinders AIDS Virus, National Institutes of Health (NIH) Study 9/11/2008
More...
|
New Study Building off Viral Genetics Inc. (VRAL)' Research Aims to Unlock the Mysteries behind Lyme Disease and Other Immune Based Diseases Including HIV/AIDS 9/11/2008
More...
|
Altor BioScience Corporation Licenses T-cell Receptors Targeting HIV and Hepatitis C from Massachusetts General Hospital 9/10/2008
More...
|
Viral Maneuvers Revealed By Surveillance System, University of Southern California Study 9/8/2008
More...
|
Nanosensor Detects Immune Cell Signals; Could Fight AIDS, Cancer 9/5/2008
More...
|
Gladstone Institute Scientists Identify Genetic Link That May Neutralize HIV 9/5/2008
More...
|
New 'Trick' Allows HIV To Overcome A Barrier To Infection, George Mason University and National Institute of Mental Health Study 9/5/2008
More...
|
Brazil Rejects Gilead Sciences, Inc. (GILD)'s AIDS Drug Patent 9/4/2008
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 9/4/2008
More...
|
Theratechnologies Inc. (TH.TO) Announces Publication in AIDS 9/2/2008
More...
|
Chemical Liberated By Leaky Gut May Allow HIV To Infect The Brain, Albert Einstein College of Medicine Scientists Find 8/19/2008
More...
|
Viral Genetics Inc. (VRAL) Unveils Potential Mechanism of Action in HIV/AIDS Research, Accepted to Present Findings at Prestigious HIV Meeting 8/19/2008
More...
|
Novartis AG MS Drug May Work Against Viral Infection, Emory University Study 8/14/2008
More...
|
Probe Into South Africa Drugs Recall 8/14/2008
More...
|
Inovio Biomedical Corporation (INO) Expands In Vivo Electroporation License with International AIDS Vaccine Initiative for HIV Vaccine Research 8/14/2008
More...
|
Genital Herpes Treatment Does Not Prevent HIV, University of Washington Study 8/12/2008
More...
|
Why Some Infected With HIV Remain Symptom Free Without Antiretroviral Drugs, Johns Hopkins University Study 8/12/2008
More...
|
'Adapter Plug' To Turn Antibodies Into HIV Killers, Karolinska Institute Study 8/12/2008
More...
|
U.S. FDA Approves Gilead Sciences, Inc. (GILD)'s Viread(R) for Chronic Hepatitis B in Adults 8/12/2008
More...
|
NanoViricides, Inc. (NNVC.PK) Reports that HIVCide-I Was Significantly Superior to the Current Anti-HIV Three Drug Cocktail Standard 8/11/2008
More...
|
Researchers Halt Spread Of HIV With RNAi In Animal Model, Harvard Medical School Study 8/8/2008
More...
|
Inverness Medical Innovations, Inc. (IMA) Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo 8/8/2008
More...
|
Ardea Biosciences, Inc. Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference 8/8/2008
More...
|
GlaxoSmithKline (GSK) Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 8/8/2008
More...
|
GlaxoSmithKline (GSK) Release: Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 8/8/2008
More...
|
Anti-HIV "Drug Cocktails" Equally Effective in Patients with or without History of Injection Drug Use, National Institute on Drug Abuse (NIDA) Study 8/7/2008
More...
|
Argos Therapeutics, Inc. and Université de Montréal Present Novel Method to Create Personalized Immunotherapy Treatments that Stimulate HIV-Specific T Cells 8/6/2008
More...
|
Rectal Gel Prevents Transmission Of AIDS-Like Virus In Macaques, St. George's University Study 8/5/2008
More...
|
Ninety-Six Week Data on Tibotec Therapeutics Investigational NNRTI, TMC278, Presented at AIDS 2008 8/5/2008
More...
|
Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization Program with Start of a Phase IIb Trial in U.S. and Europe 8/5/2008
More...
|
Argos Therapeutics, Inc. Arcelis(TM) Personalized Immunotherapy Platform in HIV Achieves Primary Endpoint in Phase 1 Trial 8/5/2008
More...
|
MedMira Inc. (MIR.V) Extends Market Reach into Southeast Asia with Contract for One Million HIV Tests 8/5/2008
More...
|
Bristol-Myers Squibb Company (BMY) Release: CASTLE Data Showed Boosted REYATAZ(R) (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender 8/5/2008
More...
|
Mixed Results For Growth Hormone In HIV Patients, Massachusetts General Hospital Study 8/4/2008
More...
|
Certain HIV Treatment Less Effective When Used With Anti-TB Therapy, University of Cape Town Study 8/4/2008
More...
|
New Male Circumcision Device For HIV Prevention, NewYork-Presbyterian Hospital/Weill Cornell Medical Center Study 8/4/2008
More...
|
New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option 8/4/2008
More...
|
Gilead Sciences, Inc. (GILD) AIDS Drugs Will Be Tested To See If They Can Prevent HIV 8/4/2008
More...
|
New HIV/AIDS Guidelines Suggest Earlier Treatment, JAMA 8/4/2008
More...
|
SA Muslim HIV Test Call Condemned 8/1/2008
More...
|
Imaging Techniques Yield New Information on How HIV Infects Cells and Provides Clues to Vaccine Design, National Cancer Institute Study 7/31/2008
More...
|
New Drug for HIV treatment, University of New South Wales Research 7/30/2008
More...
|
Sensitive Testing by CenterWatch Inc. Scientists Reveals Drug-Resistant HIV with Possible Consequences for Treatment 7/29/2008
More...
|
Ardea Biosciences, Inc. to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting 7/29/2008
More...
|
ImQuest Pharmaceuticals, Inc. Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide 7/29/2008
More...
|
Ambrilia Biopharma Inc. Provides Update on PPL-100; Merck & Co., Inc. (MRK) (JOBS) Places Development Hold on Drug 7/28/2008
More...
|
Drugs Add 13 Years To Life Of HIV Patients, Lancet Journal 7/25/2008
More...
|
US Congress OKs $48B For Global AIDS Fight 7/25/2008
More...
|
Wake Forest University Baptist Medical Center Researchers Disprove Long-Standing Belief About HIV Treatment 7/25/2008
More...
|
Merck & Co., Inc. (MRK) Reports Results of Two Pivotal Phase III First in Class Integrase Inhibitor Studies 7/24/2008
More...
|
FDA Announces Important Safety-Related Label Update for GlaxoSmithKline (GSK)'s Ziagen (abacavir sulfate) 7/24/2008
More...
|
Viral Recombination Another Way HIV Fools the Immune System, Massachusetts General Hospital Study Finds 7/23/2008
More...
|
Gilead Sciences, Inc. (GILD) Initiates Phase III Clinical Trial of Elvitegravir, an Investigational Integrase Inhibitor for HIV 7/23/2008
More...
|
HIV Overpowers Immune System Quicker than Previously Thought, Duke University Researchers Say 7/21/2008
More...
|
McGill University Researchers Study Genetic Cause of Innate Resistance to HIV/AIDS 7/18/2008
More...
|